A Prospective Blinded Study of Endoscopic Ultrasound Elastography in Liver Disease: Towards a Virtual Biopsy

다국어 초록 (Multilingual Abstract)

Background/Aims: Liver biopsy has traditionally been used for determining the degree of fibrosis, however there are several limitations. Endoscopic ultrasound (EUS) real-time elastography (RTE) is a novel technology that uses image enhancement to display differences in tissue compressibility. We sought to assess whether liver fibrosis index (LFI) can distinguish normal, fatty, and cirrhotic liver tissue.
Methods: A total of 50 patients undergoing EUS were prospectively enrolled. RTE of the liver was performed to synthesize the LFI in each patient. Univariate and multivariable analyses were performed. Chi-square and t-tests were performed for categorical and continuous variables, respectively. A p-value of <0.05 was considered significant.
Results: Abdominal imaging prior to endoscopic evaluation suggested normal tissue, fatty liver, and cirrhosis in 26, 16, and 8 patients, respectively. Patients with cirrhosis had significantly increased mean LFI compared to the fatty liver (3.2 vs. 1.7, p<0.001) and normal (3.2 vs. 0.8, p<0.001) groups. The fatty liver group showed significantly increased LFI compared to the normal group (3.8 vs. 1.4, p<0.001).
Multivariable regression analysis suggested that LFI was an independent predictor of group features (p<0.001).
Conclusions: LFI computed from RTE images significantly correlates with abdominal imaging and can distinguish normal, fatty, and cirrhotic-appearing livers; therefore, LFI may play an important role in patients with chronic liver disease.

참고문헌 (Reference)

1 Bedossa P, "Sampling variability of liver fibrosis in chronic hepatitis C" 38 : 1449-1457, 2003

2 Fraquelli M, "Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease" 56 : 968-973, 2007

3 Castera L, "Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations" 51 : 828-835, 2010

4 Tatsumi C, "Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (fibroscan) and real-time tissue elastography" 51 (51): 27-33, 2008

5 Castera L, "Non-invasive evaluation of liver fibrosis using transient elastography" 48 : 835-847, 2008

6 Tatsumi C, "Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis" 53 : 76-81, 2010

7 Berzigotti A, "Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension" 31 : 129-138, 2011

8 Pang JX, "Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease" 9 : e95776-, 2014

9 Robic MA, "Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study" 55 : 1017-1024, 2011

10 Kettaneh A, "Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients" 46 : 628-634, 2007

11 Lucidarme D, "Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C" 49 : 1083-1089, 2009

12 Wong GL, "Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population" 26 : 300-305, 2011

13 Augustin S, "Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study" 60 : 561-569, 2014

14 Chang PE, "Clinical applications, limitations and future role of transient elastography in the management of liver disease" 7 : 91-106, 2016

15 Bedossa P, "An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group" 24 : 289-293, 1996